Davis EJ - Search Results

1

Inadvertent Inguinal Sarcoma Excision during Hernia Surgery: Outcomes, Gender Analysis, and Prevention.

Lawrenz JM, Norris JP 4th, Tan MC, Shinohara ET, Block JJ, Davis EJ, Keedy VL, Halpern JL, Holt GE, Schwartz HS. Lawrenz JM, et al. Among authors: davis ej. Int J Surg Oncol. 2020 Dec 7;2020:8374790. doi: 10.1155/2020/8374790. eCollection 2020. Int J Surg Oncol. 2020. PMID: 33489372 Free PMC article.

2

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.

Pender A, Davis EJ, Chauhan D, Messiou C, Al-Muderis O, Thway K, Fisher C, Zaidi S, Miah A, Judson I, van der Graaf W, Keedy VL, Benson C, Jones RL. Pender A, et al. Among authors: davis ej. Med Oncol. 2018 Aug 20;35(10):131. doi: 10.1007/s12032-018-1193-5. Med Oncol. 2018. PMID: 30128716 Free PMC article.

3

A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.

Bui N, Dietz H, Farag S, Hirbe AC, Wagner MJ, Van Tine BA, Ganjoo K, Jones RL, Keedy VL, Davis EJ. Bui N, et al. Among authors: davis ej. Cancers (Basel). 2023 May 5;15(9):2617. doi: 10.3390/cancers15092617. Cancers (Basel). 2023. PMID: 37174084 Free PMC article.

4

Brain Metastases in Sarcomas: A Multicenter Retrospective Cohort Study.

Zhang E, Farag S, Dietz H, Wang D, Hirbe A, Ganjoo K, Van Tine B, Zaid S, Miah A, Keedy V, Davis E, Bui N. Zhang E, et al. Cancers (Basel). 2024 Nov 7;16(22):3760. doi: 10.3390/cancers16223760. Cancers (Basel). 2024. PMID: 39594714 Free PMC article.

5

Association of Anti-Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma.

Quach HT, Dewan AK, Davis EJ, Ancell KK, Fan R, Ye F, Johnson DB. Quach HT, et al. Among authors: davis ej. JAMA Oncol. 2019 Jun 1;5(6):906-908. doi: 10.1001/jamaoncol.2019.0046. JAMA Oncol. 2019. PMID: 30998826 Free PMC article.

6

What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?

Kasper B, D'Ambrosio L, Davis EJ, Ingham M, Broto JM, Trent JC, van Houdt WJ, Van Tine BA. Kasper B, et al. Among authors: davis ej. Curr Treat Options Oncol. 2022 Mar;23(3):439-449. doi: 10.1007/s11864-021-00928-y. Epub 2022 Mar 11. Curr Treat Options Oncol. 2022. PMID: 35275323 Free PMC article. Review.

7

A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.

Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM. Davis EJ, et al. Eur J Cancer. 2015 Sep;51(13):1794-802. doi: 10.1016/j.ejca.2015.05.010. Epub 2015 Jun 9. Eur J Cancer. 2015. PMID: 26066736 Clinical Trial.

8

Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.

Davis EJ, Chugh R. Davis EJ, et al. Drug Des Devel Ther. 2017 Dec 13;11:3579-3587. doi: 10.2147/DDDT.S121298. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29263653 Free PMC article. Review.

9

Targeting tissue factor in advanced solid tumours.

Davis EJ, Johnson DB. Davis EJ, et al. Lancet Oncol. 2019 Mar;20(3):318-319. doi: 10.1016/S1470-2045(18)30912-4. Epub 2019 Feb 8. Lancet Oncol. 2019. PMID: 30745091 No abstract available.

10

Clinical Correlates of Response to Anti-PD-1-based Therapy in Patients With Metastatic Melanoma.

Davis EJ, Perez MC, Ayoubi N, Zhao S, Ye F, Wang DY, Sosman JA, Al-Rohil RN, Eroglu Z, Johnson DB. Davis EJ, et al. J Immunother. 2019 Jul-Aug;42(6):221-227. doi: 10.1097/CJI.0000000000000258. J Immunother. 2019. PMID: 30882548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters